GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (XSWX:BION) » Definitions » E10

BB Biotech AG (XSWX:BION) E10 : CHF4.91 (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is BB Biotech AG E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BB Biotech AG's adjusted earnings per share data for the three months ended in Dec. 2023 was CHF1.990. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is CHF4.91 for the trailing ten years ended in Dec. 2023.

During the past 12 months, BB Biotech AG's average E10 Growth Rate was -1.30% per year. During the past 3 years, the average E10 Growth Rate was -1.60% per year. During the past 5 years, the average E10 Growth Rate was 4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of BB Biotech AG was 11.40% per year. The lowest was -1.60% per year. And the median was 3.75% per year.

As of today (2024-05-01), BB Biotech AG's current stock price is CHF41.35. BB Biotech AG's E10 for the quarter that ended in Dec. 2023 was CHF4.91. BB Biotech AG's Shiller PE Ratio of today is 8.42.

During the past 13 years, the highest Shiller PE Ratio of BB Biotech AG was 9.01. The lowest was 5.62. And the median was 7.27.


BB Biotech AG E10 Historical Data

The historical data trend for BB Biotech AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG E10 Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.27 7.38 12.82 6.43 4.91

BB Biotech AG Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.43 5.79 4.51 4.66 4.91

Competitive Comparison of BB Biotech AG's E10

For the Biotechnology subindustry, BB Biotech AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Shiller PE Ratio falls into.



BB Biotech AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BB Biotech AG's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.99/106.4611*106.4611
=1.990

Current CPI (Dec. 2023) = 106.4611.

BB Biotech AG Quarterly Data

per share eps CPI Adj_EPS
201106 -0.925 102.678 -0.959
201109 -1.415 101.811 -1.480
201112 1.462 101.408 1.535
201203 3.096 101.826 3.237
201206 2.172 101.596 2.276
201209 2.014 101.392 2.115
201212 -2.204 100.968 -2.324
201303 6.330 101.221 6.658
201306 2.280 101.466 2.392
201309 5.980 101.336 6.282
201312 1.764 101.036 1.859
201403 1.154 101.224 1.214
201406 3.446 101.517 3.614
201409 8.530 101.247 8.969
201412 12.836 100.704 13.570
201503 6.750 100.339 7.162
201506 6.000 100.464 6.358
201509 -10.320 99.785 -11.010
201512 9.150 99.386 9.801
201603 -21.750 99.475 -23.277
201606 0.640 100.088 0.681
201609 7.170 99.604 7.664
201612 -0.450 99.380 -0.482
201703 6.770 100.040 7.205
201706 1.870 100.285 1.985
201712 12.420 100.213 13.194
201812 -8.510 100.906 -8.978
201912 12.230 101.063 12.883
202012 12.480 100.241 13.254
202103 3.990 100.800 4.214
202106 2.320 101.352 2.437
202112 -7.310 101.776 -7.647
202203 -5.430 103.205 -5.601
202206 -4.230 104.783 -4.298
202209 3.830 104.835 3.889
202212 -0.640 104.666 -0.651
202303 -4.630 106.245 -4.639
202306 -0.240 106.576 -0.240
202309 -0.890 106.570 -0.889
202312 1.990 106.461 1.990

Add all the adjusted EPS together and divide 10 will get our e10.


BB Biotech AG  (XSWX:BION) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BB Biotech AG's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=41.35/4.91
=8.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of BB Biotech AG was 9.01. The lowest was 5.62. And the median was 7.27.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BB Biotech AG E10 Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG (XSWX:BION) Business Description

Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.
Executives
Prof. Dr. Mads Krogsgaard Thomsen Supervisory Board

BB Biotech AG (XSWX:BION) Headlines

No Headlines